DIDB® – The Drug Interaction Database, is now part of Certara
PRINCETON, N.J.— 2023 年 6 月 20 日 — Certara, Inc. （纳斯达克股票代码：CERT), today announced it has acquired…
Certara2023 年 6 月 21 日
Certara Appoints new Chief Marketing Officer, Sheila Rocchio
Princeton, N.J., 2023 年 6 月 13 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today…
Certara2023 年 6 月 14 日
What’s New for SEND 2023
This webinar will focus on several changes to the CDISC SEND standard that became active…
Certara2023 年 6 月 12 日
Certara Launches Version 8.4 of Phoenix™ Biosimulation Software for Drug Development
Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.— June…
Certara2023 年 6 月 12 日
Certara enhances CODEX Clinical Outcome Analytics Platform with AI
Trial design and execution now accelerated by deep learning and data fabric capabilities. PRINCETON, NJ…
Certara2023 年 6 月 8 日
Unlocking Efficiency and Quality: What is New in Phoenix™️ 8.4?
Join us for an exclusive webinar as Certara introduces the highly anticipated version 8.4 of…
Certara2023 年 6 月 5 日
QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation
Typical Quantitative Systems Pharmacology (QSP) workflows involve discussion of biology, supported by graphical diagrams, followed…
Certara2023 年 5 月 25 日
